Sereno D - Search Results

1

Leishmania amastigotes as targets for drug screening.

Monte-Alegre A, Ouaissi A, Sereno D. Monte-Alegre A, et al. Among authors: sereno d. Kinetoplastid Biol Dis. 2006 Oct 23;5:6. doi: 10.1186/1475-9292-5-6. Kinetoplastid Biol Dis. 2006. PMID: 17059597 Free PMC article.

2

Experimental study of the function of the excreted/secreted Leishmania LmSIR2 protein by heterologous expression in eukaryotic cell line.

Sereno D, Vanhille L, Vergnes B, Monte-Allegre A, Ouaissi A. Sereno D, et al. Kinetoplastid Biol Dis. 2005 Jan 24;4(1):1. doi: 10.1186/1475-9292-4-1. Kinetoplastid Biol Dis. 2005. PMID: 15667659 Free PMC article.

3

Targeted disruption of cytosolic SIR2 deacetylase discloses its essential role in Leishmania survival and proliferation.

Vergnes B, Sereno D, Tavares J, Cordeiro-da-Silva A, Vanhille L, Madjidian-Sereno N, Depoix D, Monte-Alegre A, Ouaissi A. Vergnes B, et al. Among authors: sereno d. Gene. 2005 Dec 19;363:85-96. doi: 10.1016/j.gene.2005.06.047. Epub 2005 Oct 19. Gene. 2005. PMID: 16236469

4

Proof of interaction between Leishmania SIR2RP1 deacetylase and chaperone HSP83.

Adriano MA, Vergnes B, Poncet J, Mathieu-Daude F, da Silva AC, Ouaissi A, Sereno D. Adriano MA, et al. Among authors: sereno d. Parasitol Res. 2007 Mar;100(4):811-8. doi: 10.1007/s00436-006-0352-3. Epub 2006 Nov 10. Parasitol Res. 2007. PMID: 17096142

5

Advances and perspectives in Leishmania cell based drug-screening procedures.

Sereno D, Cordeiro da Silva A, Mathieu-Daude F, Ouaissi A. Sereno D, et al. Parasitol Int. 2007 Mar;56(1):3-7. doi: 10.1016/j.parint.2006.09.001. Epub 2006 Oct 31. Parasitol Int. 2007. PMID: 17079188 Review.

6

Glutathione S-transferases and related proteins from pathogenic human parasites behave as immunomodulatory factors.

Ouaissi A, Ouaissi M, Sereno D. Ouaissi A, et al. Among authors: sereno d. Immunol Lett. 2002 May 1;81(3):159-64. doi: 10.1016/s0165-2478(02)00035-4. Immunol Lett. 2002. PMID: 11947919 Review.

7

Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death.

Vergnes B, Sereno D, Madjidian-Sereno N, Lemesre JL, Ouaissi A. Vergnes B, et al. Among authors: sereno d. Gene. 2002 Aug 21;296(1-2):139-50. doi: 10.1016/s0378-1119(02)00842-9. Gene. 2002. PMID: 12383511

8

Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase.

Vergnes B, Vanhille L, Ouaissi A, Sereno D. Vergnes B, et al. Among authors: sereno d. Acta Trop. 2005 May;94(2):107-15. doi: 10.1016/j.actatropica.2005.03.004. Epub 2005 Apr 26. Acta Trop. 2005. PMID: 15860278

9

Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.

Sereno D, Cavaleyra M, Zemzoumi K, Maquaire S, Ouaissi A, Lemesre JL. Sereno D, et al. Antimicrob Agents Chemother. 1998 Dec;42(12):3097-102. doi: 10.1128/AAC.42.12.3097. Antimicrob Agents Chemother. 1998. PMID: 9835497 Free PMC article.

10

Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes.

Sereno D, Holzmuller P, Mangot I, Cuny G, Ouaissi A, Lemesre JL. Sereno D, et al. Antimicrob Agents Chemother. 2001 Jul;45(7):2064-9. doi: 10.1128/AAC.45.7.2064-2069.2001. Antimicrob Agents Chemother. 2001. PMID: 11408224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters